IP Library Granted Patent US 9,765,220
Granted Patent B2
US 9,765,220 · App. 14/913,675 · Granted Sep 19, 2017

Water soluble fluorescent or colored dyes and methods for their use

Inventors: Tracy Matray (Snohomish, WA); Hesham Sherif (Redmond, WA); C. Frederick Battrell (Wenatchee, WA)
Assignees: SONY CORPORATION; SONY CORPORATION OF AMERICA
C09B3/14C07F9/094C07F9/098C07F9/5765C07F9/65522C07H21/04C09B1/00C09B5/62C09B11/24C09B57/001C09B57/08C09B69/103C09B69/109G01N33/582G01N33/583
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,765,220
App. No.
14/913,675
Granted
Sep 19, 2017
Kind
B2
Abstract

Compounds useful as fluorescent or colored dyes are disclosed. The compounds have the following structure (I): including stereoisomers, salts and tautomers thereof, wherein R 1 , R 2 , R 3 , L 1 , L 2 , L 3 , L 4 , L 5 , L 6 , M 1 , M 2 , A, q, w and n are as defined herein. Methods associated with preparation and use of such compounds are also provided.

Claims (66)

1. A compound having the following structure (III):

wherein:

M 1 and M 2 are, at each occurrence, independently a moiety comprising two or more double bonds and at least one degree of conjugation, and at least one occurrence of M 1 is a moiety comprising three or more aryl or heteroaryl rings, or combinations thereof;

L 1 , L 3 , L 4 L 6 , L 7 and L 8 are, at each occurrence, independently optional alkylene or heteroalkylene linkers;

R 1 is, at each occurrence, independently H, alkyl or alkoxy;

R 2 is an electron pair, H, alkyl, alkylether, hydroxylalkyl, aminoalkyl, hydroxylalkylether, sulfhydrylalkyl, sulfyhdrylalkylether, cyanoalkyl, phospho, thiophospho, alkylphospho, alkylthiophospho, alkyletherphospho, alkyletherthiophospho, phosphoalkyl, phosphoalkylether, thiophosphoalkyl or thiophosphoalkylether, or R 2 is a linker comprising a covalent bond to a biomolecule or microparticle;

R 3 is H, OH, SH, —NH 2 , alkyl, alkylether, hydroxylalkyl, aminoalkyl, hydroxylalkylether, sulfhydrylalkyl, sulfyhdrylalkylether, cyanoalkyl, —Oaralkyl, phosphate, thiophosphate, alkylphospho, alkylthiophospho, —Oalkylphospho, —Oalkylthiophospho, alkyletherphospho, alkyletherthiophospho, —Oalkyletherphospho, —Oalkyletherthiophospho phosphoalkyl, phosphoalkylether, thiophosphoalkyl, thiophosphoalkylether, —Ophosphoalkyl, O-phosphoalkylether, —Othiophosphoalkyl or —Othiophosphoalkylether;

R 4 is, at each occurrence, independently O − , S − , OZ, SZ or N(R 6 ) 2 , where Z is a cation and each R 6 is independently H or alkyl;

R 5 is, at each occurrence, independently oxo, thioxo or absent;

n is an integer from 2 to 20; and

q and w are each independently 0 or 1 for each integral value of n, wherein q is 1 for at least two integral values of n, or wherein q and w are each independently one for at least one integral value of n.

2. The compound of claim 1 , wherein the compound has the following structure (IIa):

wherein:

M 1 is, at each occurrence, independently a moiety comprising two or more double bonds and at least one degree of conjugation, and at least one occurrence of M 1 is a moiety comprising four or more aryl or heteroaryl rings, or combinations thereof;

L 1 , L 7 and L 3 are, at each occurrence, independently optional alkylene or heteroalkylene linkers;

R 1 is, at each occurrence, independently H, alkyl or alkoxy;

R 2 is H, alkyl, alkylether, hydroxylalkyl, aminoalkyl, hydroxylalkylether, sulfhydrylalkyl, sulfyhdrylalkylether, cyanoalkyl, phospho, thiophospho, alkylphospho, alkylthiophospho, alkyletherphospho, alkyletherthiophospho, phosphoalkyl, phosphoalkylether, thiophosphoalkyl or thiophosphoalkylether, or R 2 is a linker comprising a covalent bond to a biomolecule or microparticle;

R 3 is H, OH, SH, —NH 2 , alkyl, alkylether, hydroxylalkyl, aminoalkyl, hydroxylalkylether, sulfhydrylalkyl, sulfyhdrylalkylether, cyanoalkyl, —Oaralkyl, phosphate, thiophosphate, alkylphospho, alkylthiophospho, —Oalkylphospho, —Oalkylthiophospho, alkyletherphospho, alkyletherthiophospho, —Oalkyletherphospho, —Oalkyletherthiophospho phosphoalkyl, phosphoalkylether, thiophosphoalkyl, thiophosphoalkylether, —Ophosphoalkyl, O-phosphoalkylether, —Othiophosphoalkyl or —Othiophosphoalkylether;

R 4 is, at each occurrence, independently O − , S − , OZ, SZ or N(R 6 ) 2 , where Z is a cation and each R 6 is independently H or alkyl;

R 5 is, at each occurrence, independently oxo, thioxo or absent; and

n is an integer from 2 to 10.

3. The compound of claim 1 , wherein the compound has one of the following structures (IIc), (IId), (IIe) or (IIf):

4. The compound of claim 1 , wherein the compound has the following structure (IIIb):

wherein:

R 7 , R 8 , R 9 , R 10 , R 11 and R 12 are, at each occurrence, independently H or alkyl; and

x 1 , x 2 , y 1 , y 2 , z 1 and z 2 are, at each occurrence, independently an integer from 0 to 5.

5. The compound of claim 1 , wherein R 2 has one of the following structures:

wherein:

R 2a is —OH, —NH 2 , or —SH; and

a is an integer from 1 to 10.

6. The compound of claim 1 , wherein R 2 has one of the following structures:

wherein:

R 2a is —OH, —SH, —NH 2 , phosphate or thiophosphate;

R 4a and R 4b are independently O − , S − , OZ or SZ, where Z is a cation;

R 5a and R 5b are independently oxo, or thioxo; and

a, b and c are each independently integers from 1 to 10.

7. The compound of claim 1 , wherein R 3 is OH.

8. The compound of claim 1 , wherein R 3 has one of the following structures:

wherein:

R 3a is —OH, —SH, —NH 2 , phosphate or thiophosphate;

R 4a and R 4b are independently O − , S − , OZ or SZ, where Z is a cation;

R 5a and R 5b are independently oxo, or thioxo; and

b and c are each independently integers from 1 to 10.

9. The compound of claim 1 , wherein at least one M 1 is a moiety comprising four or more aryl or heteroaryl rings, or combinations thereof.

10. The compound of claim 1 , wherein M 1 is, at each occurrence, independently fluorescent or colored.

11. The compound of claim 1 , wherein M 1 has one of the following structures:

12. The compound of claim 1 , wherein R 2 is a linker comprising a covalent bond to a biomolecule or microparticle, and R 3 is H, OH, phosphate, thiophosphate, phosphoalkyl, —Ophosphoalkyl, phosphoalkylether, —Ophosphoalkylether, thiophosphoalkyl, —Othiophospho, thiophosphoalkylether or —Othiophosphoalkylether.

13. A compound having one of the following structures:

14. A method of staining a sample, comprising adding to said sample the compound of claim 12 in an amount sufficient to produce an optical response when said sample is illuminated at an appropriate wavelength.

15. A method for visually detecting a biomolecule, the method comprising:

(a) providing the compound of claim 12 ; and

(b) detecting the compound by its visible properties.

16. A method for visually detecting a biomolecule, the method comprising:

(a) admixing the compound of claim 1 with one or more biomolecules; and

(b) detecting the compound by its visible properties.

17. A composition comprising the compound of claim 1 and one or more biomolecules.

18. The compound of claim 1 , wherein R 2 is hydroxylalkyl, aminoalkyl, hydroxylalkylether, sulfhydrylalkyl or sulfhydrylalkylether.

19. The compound of claim 1 , wherein R 2 is alkylphospho, alkylthiophospho, alkyletherphospho, alkyletherthiophospho, phosphoalkyl, phosphoalkylether, thiophosphoalkyl or thiophosphoalkylether, wherein R 2 is optionally substituted with a substituent selected from —OH, —NH 2 , and —SH.

20. The compound of claim 1 , wherein R 3 is, phosphate, thiophosphate, phospho, thiophospho, —Oalkylphospho, —Oalkylthiophospho, —Oalkyletherphospho, —Oalkyletherthiophospho, —Ophosphoalkyl, —Ophosphoalkylether, —Othiophosphoalkyl or —Othiophosphoalkylether optionally substituted with a substituent selected from —OH, —NH 2 , and —SH.

21. The compound of claim 1 , wherein n is an integer from 2 to 15.

22. The compound of claim 1 , wherein each M 1 is pyrene, perylene, perylene monoimide or 6-FAM or derivative thereof.

23. The compound of claim 1 , wherein R 2 is a linker comprising a covalent bond to a biomolecule.

24. The compound of claim 23 , wherein the biomolecule is an enzyme, receptor, receptor ligand, antibody, glycoprotein, aptamer or prion.

25. The method of claim 14 , wherein said optical response is a fluorescent response.

26. The method of claim 14 , wherein said sample comprises cells.

27. The method of claim 26 , further comprising observing said cells by flow cytometry.

Assignments (3)
CHANGE OF NAME Recorded Mar 24, 2025
From: SONY CORPORATION
To: SONY GROUP CORPORATION
Reel/Frame 070610/0947 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2020
From: SONY CORPORATION OF AMERICA
To: SONY CORPORATION
Reel/Frame 054751/0070 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2017
From: MATRAY, TRACY; SHERIF, HESHAM; BATTRELL, C. FREDERICK
To: SONY CORPORATION; SONY CORPORATION OF AMERICA
Reel/Frame 041622/0532 →
Continuity (2)
Provisional Application 61868973 · Aug 22, 2013
Related Publication 20160208100A1 · Jul 21, 2016